慕尚集團控股(01817.HK)出資6000萬元與萬成成立服裝公司 持股60%
格隆匯12月2日丨慕尚集團控股(01817.HK)公佈,公司與萬成資源有限公司訂立合營企業協議,自2019年12月2日起生效,以於中國成立一間合營企業公司。
根據合營協議,合營公司將由公司持有60%及由萬成持有40%。合營公司的註冊資本應為人民幣1億元,當中公司及萬成須分別投入人民幣6000萬元及人民幣4000萬元。
據悉,合營公司將主要於中國為思捷品牌從事經營服裝、服飾配件及訂約方可能協定的其他業務。合營公司的業務範圍將包括一般家用商品、衣服及配飾、鞋履、帽子、皮革製品、運動產品、化粧品的零售、批發、進出口,以及佣金代理及提供相關服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.